ANEMIA DRUGS DSN KEVIN DOBI, MS, APRN Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Chapter 54.

Slides:



Advertisements
Similar presentations
ANEMIA IN PREGNANCY O+G Update 2014 Hospital Sarikei.
Advertisements

Adrianna Machelska. Diseases of blood and hematopoietic system are less known but very important part of medical science. We encounter them every day,
Dr. Soban sadiq. Oral Therapy: Ferrous Sulphate Ferrous Fumarate Ferrous Gluconate Parenteral Therapy: Iron Dextran Iron-sucrose complex Iron sodium.
Hypochromic/Microcytic Anemias. (NORMO)/ HYPOCHROMIC &/or (NORMO)/ MICROCYTIC ANEMIAS 1. Disorders of iron utilization a. iron deficiency b. anemia of.
Drug therapy of Anaemias March Anaemia Defined as a reduced number of circulating red blood cells Defined as a reduced number of circulating red.
Anti-Anemia Agents Broyles Chapter 22 Lehmkuhl, 2009.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Neel Bhalala (2009) Sofia Medical University. Background  Erythropoiesis-stimulating agents are man-made versions of a natural protein known as erythropoietin.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 55 Anemia Drugs.
Alterations of Erythrocyte Function
CLUES TO THE DIAGNOSIS IN ANEMIA PRINCIPLES 4 Anemia is not a disease 4 There is usually a cause 4 investigation should be logical 4 Start with CBC and.
Agents Used to Treat Anemias. Anemia Decreased number of circulating red blood cells Decreased hemoglobin = decreased oxygen capacity Many causes. 22.
HEMATOPOIETIC AND ANTI- ANEMIA AGENTS February 18, 2014 Thomas M. Guenthner, PhD 407D, MSB
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias.
Chapter Seven - Part Two The Trace Minerals & Water Food & Nutritional Health NUT SCI –242 Karen Lacey, MS, RD, CD © Spring 2005.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
Antianemics Prof. Hanan Hagar
Iron supplements Prepared by: AbdulRahman I. Bin Muhanna.
Anemias. Body Contents of Iron Structure of Hemoglobin.
Clinical aspects of Maternal and Child Nursing NUR 363 Lecture 8.
The blood cells may lack enough hemoglobin, the protein that gives blood its red color. Anemia affects one in 10 teen girls and women. It also develops.
Chapter 7 Diseases of the Blood. Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Terms  Erythrocytes: Red blood cells.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 45 Immunosuppressant Drugs.
NURSING CARE OF THE CHILD WITH A HEMATOLOGIC ALTERATION.
Copyright © 2009, by Mosby, Inc. an affiliate of Elsevier, Inc. All rights reserved.1 Chapter 16 Nutrition and Physical Fitness.
FATIMA DARAKHSHAN (2K10-BS-V&I-35)
Chapter 22 Agents Used to Treat Anemias. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Anemia.
PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT
PROMOTING GOOD NUTRITION Chapter 9. Nutritional Policies are important in Child Care Child care facilities serve at least 1 meal a day to about 5 million.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
Control of erythropoiesis, iron metabolism, and hemoglobin
Mosby items and derived items © 2006 by Mosby, Inc. Slide 1 Chapter 5 Vitamins.
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 56 Blood-Forming Drugs.
Hematological System KNH 413. Nutritional Anemias Macrocytic –B12, B9, B1, pyridoxine (B??) Decreased ability to synthesize new cells and DNA Microcytic.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Central Nervous System Stimulants and Related.
ERYTHROPOIESIS- STIMULATING AGENTS. Patients who are no longer able to produce enough erythropoietin in the kidneys may benefit from treatment with.
AGENTS FOR MEGALOBLASTIC ANEMIAS. Megaloblastic anemia is treated with folic acid and vitamin B12. Folate deficiencies usually occur secondary to increased.
AGENTS USED FOR IRON DEFICIENCY
AGENT FOR SICKLE CELL ANEMIA
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 45 Immunosuppressant Drugs.
BLOOD DISORDERS.
Chapter 22 Agents Used to Treat Anemias. Anemia p526 Decrease in hemoglobin or decrease in RBCs Many causes of anemia – Iron deficiency anemia – Chemotherapy.
TREATMENT IRON DEFICIENCY ANEMIA. 3 Approaches in the Treatment of IDA: 1.Red Cell Transfusion 2.Oral Iron Therapy 3.Parenteral Iron Therapy Braunwald.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 63 Care of Patients with Malnutrition and Obesity.
Hematological System KNH 413. Nutritional Anemias Macrocytic – Folate, Thiamin, B12 Decreased ability to synthesize new cells and DNA Microcytic – Protein,
The Trace Minerals.
Copyright © 2009 Pearson Education, Inc., publishing as Benjamin Cummings Photomicrograph of a Blood Smear -- review Figure Which type of blood.
Hematologic Problems Klecka, Spring 2016.
PRACTICE TEACHING ON THALASSEMIA. INTRODUCTION O Inherited blood disorder O an abnormal form of hemoglobin due to a defect through a genetic mutation.
ANEMIA. Key points Anemia is not a specific disease state but a sign of an underlying disorder There are several kinds of anemia. A physiologic approach.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Anemia.
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
MLAB Hematology Keri Brophy-Martinez
Drugs Used in Anemia.
Copyright © 2016 by Mosby, an imprint of Elsevier Inc.
Hematological System KNH 413.
MEGALOBLASTIC ANAEMIA
Unit 34 Care of the client with Gastric Carcinoma
Hematological System KNH 413.
Hematological System KNH 413.
Drugs Used in Anemia.
Clinical pharmacy laboratory/4 th Class Anemias and blood disorders
Cholinesterase Inhibitors: Actions and Uses
CSFs are a group of immunostimulants used in cancer treatment and chronic renal failure to support the hematopoietic system. other agents used to modify.
Presentation transcript:

ANEMIA DRUGS DSN KEVIN DOBI, MS, APRN Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Chapter 54

Formation of new blood cells  Red blood cells (RBCs)  White blood cells (WBCs)  Platelets Hematopoiesis Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 2

RBCs  Manufactured in bone marrow  Immature RBCs are reticulocytes  Lifespan is 120 days More than one third of an RBC is made of hemoglobin  Heme: red pigment, contains iron  Globin: protein chain Hematopoiesis (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 3

4

Maturation defects  Cytoplasmic  Nuclear Excessive destruction of RBCs (hemolytic anemias)  Intrinsic RBC abnormalities  Extrinsic mechanisms Anemias Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 5

6

7

8

9

epoetin alfa (Epogen)  Biosynthetic form of the natural hormone erythropoietin  Used for treatment of anemia associated with end-stage renal disease, chemotherapy-induced anemia, and for anemia associated with zidovudine therapy Erythropoiesis Stimulating Agents Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 10

Erythropoiesis Stimulating Agents (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 11 epoetin alfa (Epogen)  Longer acting form of epoetin called darbepoetin (Aranesp)  Contraindications: drug allergy, uncontrolled hypertension, head and neck cancers, risk of thrombosis

Classroom Response Question Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 12 Before administering epoetin alfa to a patient in renal failure, it is most important for the nurse to assess which laboratory result? A.BUN B.White blood cell count C.Hemoglobin level D.Urine specific gravity

Essential mineral in the body Oxygen carrier in hemoglobin and myoglobin Stored in the liver, spleen, and bone marrow Iron deficiency results in anemia Iron Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 13

Dietary sources: meats, certain vegetables and grains Dietary iron must be converted by gastric juices before it can be absorbed Iron (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 14

Classroom Response Question Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 15 Which food will the nurse teach the patient to avoid when ingesting an iron supplement? A.Eggs B.Veal C.Orange juice D.Fish

Some foods enhance iron absorption  Orange juice  Veal  Fish  Ascorbic acid Some foods impair iron absorption  Eggs*  Corn  Beans*  Cereal products containing phytates * Also common dietary sources of iron Iron (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 16

Supplemental iron may be given as a single drug or as part of a multivitamin preparation Oral iron preparations are available as ferrous salts  ferrous fumarate (Femiron), ferrous gluconate, ferrous sulfate(FeSO 4 ) Parenteral  iron dextran (INFeD, Dexferrum)  iron sucrose (Venofer)  ferric gluconate (Ferrlecit)  ferumoxytol (Feraheme) Iron (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 17

Prevention and treatment of iron-deficiency syndromes Administration of iron alleviates the symptoms of iron-deficiency anemia, but the underlying cause of the anemia should be corrected Iron: Indications Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 18

Most common cause of pediatric poisoning deaths Causes nausea, vomiting, diarrhea, constipation, and stomach cramps and pain Causes black, tarry stools Liquid oral preparations may stain teeth Injectable forms cause pain upon injection Iron: Adverse Effects Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 19

Symptomatic and supportive measures  Suction and maintenance of the airway, correction of acidosis, control of shock and dehydration with intravenous fluids or blood, oxygen, and vasopressors In patients with severe symptoms of iron intoxication, such as coma, shock, or seizures, chelation therapy with deferoxamine is initiated Deferiprone is used in iron overload Iron Toxicity Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 20

Iron dextran (INFeD, Dexferrum)  May cause anaphylactic reactions, including major orthostatic hypotension and fatal anaphylaxis  Test dose of 25 mg of iron dextran is administered before injection of the full dose, and then remainder of dose is given after 1 hour  Used less frequently now; replaced by newer products ferric gluconate and iron sucrose Parenteral Iron Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 21

Ferric gluconate (Ferrlecit)  Indicated for repletion of total body iron content in patients with iron-deficiency anemia who are undergoing hemodialysis  Risk of anaphylaxis is much less than with iron dextran, and a test dose is not required  Doses higher than 125 mg are associated with increased adverse events, including abdominal pain, dyspnea, cramps, and itching Parenteral Iron Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 22

Classroom Response Question Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 23 The nurse has administered iron intravenously to a patient. To prevent orthostatic hypotension, it is recommended that the nurse have the patient remain in the recumbent position for how long? A.10 minutes B.30 minutes C.60 minutes D.90 minutes

Water-soluble, B-complex vitamin Essential for erythropoiesis Primary uses  Folic acid deficiency  During pregnancy to prevent neural tube defects Malabsorption syndromes are the most common cause of deficiency Folic Acid Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 24

Should not be used until actual cause of anemia is determined May mask symptoms of pernicious anemia, which requires treatment other than folic acid Untreated pernicious anemia progresses to neurologic damage Folic Acid (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 25

Classroom Response Question Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 26 The use of folic acid to prevent fetal neural tube defects should be started: A.during a woman’s adolescence. B.at least 1 month before pregnancy. C.when a pregnancy is first discovered. D.at the beginning of the last trimester of pregnancy.

Cyanocobalamin (Vitamin B 12 ) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 27 Used to treat pernicious anemia and other megaloblastic anemias Administered orally or intranasally to treat vitamin B 12 deficiency Usually administered by deep intramuscular injection

Assess patient history and medication history, including drug allergies Assess for potential contraindications Assess baseline laboratory values, especially Hgb, Hct, reticulocytes, others Obtain nutritional assessment Nursing Implications Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 28

Ferrous salts are contraindicated in patients with ulcerative colitis, PUD, liver disease, and other GI disorders Keep away from children because oral forms may look like candy Iron dextran is contraindicated in all anemias except for iron-deficiency anemia Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 29

For liquid iron preparations, follow manufacturer’s guidelines on dilution and administration Instruct patient to take liquid iron preparations through a straw to avoid staining tooth enamel Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 30

Oral forms of iron should be taken between meals for maximum absorption, but may be taken with meals if GI distress occurs Oral forms should be given with juice, but not with milk or antacids Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 31

Patients should remain upright for 15 to 30 minutes after oral iron doses to avoid esophageal corrosion Patients should be encouraged to eat foods high in iron/folic acid Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 32

For iron dextran, a small test dose should be given  After 1 hour, if no reaction, the remainder of the dose can be given  Administer deeply into a large muscle mass using the Z-track method Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 33

For IV doses of iron dextran, give carefully according to manufacturer’s instructions Have resuscitative equipment available in case of anaphylactic reaction Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 34

Determine cause of anemia before administering folic acid Administer oral folic acid with food Folic acid may also be given IV and added to total parenteral nutrition solutions Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 35

Monitor for therapeutic responses  Improved nutritional status  Increased weight, activity tolerance, well-being  Absence of fatigue Monitor for adverse effects Nursing Implications (cont’d) Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 36

Classroom Response Question Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 37 Which action does the nurse perform when administering iron intravenously? A.Premedicate the patient with an antihistamine to prevent anaphylaxis B.Administer the iron with a running dextrose solution C.Flush the intravenous line with 10 mL of normal saline D.Have available Regitine to reverse vasoconstriction at the site should infiltration occur